Table 2 Study outcome comparison between the early and late awake prone group
From: Early versus late awake prone positioning in non-intubated patients with COVID-19
Outcomes | Early Awake Prone (n = 92) | Late Awake Prone (n = 33) | P value |
|---|---|---|---|
 28 day mortality, n (%) | 24 (26) | 15 (45) | 0.039 |
Death without intubation, n (%) | 7 (7.6) | 6 (18.2) | 0.088 |
Hospital LOS (d), median (IQR) | 13.97 (9.64–24.9) | 12.53 (9–20.9) | 0.66 |
ICU LOS (d), median (IQR) | 7.91 (4.25–21) | 8 (3.38–16.9) | 0.55 |
IMV use, n (%) | 34 (37) | 14 (42.4) | 0.58 |
IMV duration (d), median (IQR) | 10.59 ± 6.12 | 8.89 ± 6.10 | 0.43 |
Time from HFNC start to intubation (d), median (IQR) | 5.13 (1.89–10.85) | 5.27 (3.2–9.56) | 0.65 |
Time from APP start to intubation (d), median (IQR) | 4.73 (1.85–10.6) | 3.12 (1.31–8.23) | 0.37 |
NIV use, n (%) | 23 (25) | 5 (15.2) | 0.24 |
Time from HFNC start to NIV (d), median (IQR) | 3.74 (0.83–9.61) | 2.11 (0.7–8.95) | 0.77 |
ECMO use, n (%) | 2 (2.2) | 0 | 0.54 |
Inhaled vasodilator use, n (%) | 26 (28.3) | 9 (27.3) | 0.28 |